RESEARCH PAPER
No effect of 3-(N-p-isopropoxyphenylsuccinimidomethylamino)-cinnamic acid on anticonvulsant action of different classical antiepileptic drugs in mouse maximal electroshock-induced seizure model
 
More details
Hide details
1
Isobolographic Analysis Laboratory, Institute of Rural Health, Lublin, Poland
 
2
Department of Pathophysiology, Medical University, Lublin, Poland
 
3
Mndjoyan’s Institute of Fine Organic Chemistry, National Academy of Sciences, Yerevan, Republic of Armenia
 
4
Department of Public Health, Institute of Rural Health, Lublin, Poland
 
 
Corresponding author
Jarogniew J. Łuszczki   

Isobolographic Analysis Laboratory, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland.
 
 
J Pre Clin Clin Res. 2012;6(1):20-24
 
KEYWORDS
ABSTRACT
Introduction and objective:
The aim of the study was to determine the effects of 3-(N-p-isopropoxyphenylsuccinimidomethylamino)-cinnamic acid (IPPSMA-CA – a new succinimide derivative) on the protective action of 4 classical antiepileptic drugs (AEDs): carbamazepine [CBZ], phenobarbital [PB], phenytoin [PHT] and valproate [VPA]), against maximal electroshock (MES)-induced tonic seizures in mice.

Material and Methods:
Tonic hind limb extension (seizure activity) was evoked in adult male albino Swiss mice by a current (sine-wave, 25 mA, 500 V, 50 Hz, 0.2 s stimulus duration) delivered via auricular electrodes. Acute adverse-effect profiles of the combination of IPPSMA-CA and 4 classical AEDs (CBZ, PB, PHT and VPA) with respect to motor performance, long-term memory and skeletal muscular strength were measured in the chimney, passive avoidance and grip-strength tests, respectively.

Results:
IPPSMA-CA administered at 150 mg/kg (i.p.) significantly elevated the threshold for electroconvulsions in mice (p<0.01). IPPSMA-CA at doses of 50 and 100 mg/kg, however, had no significant impact on the threshold for electroconvulsions in mice. Nor did IPPSMA-CA (100 mg/kg) significantly affect the anticonvulsant activity of CBZ, PB, PHT and VPA in the MES test in mice. None of the examined combinations of IPPSMA-CA (100 mg/kg, i.p.) with CBZ, PB, PHT and VPA (at their ED50 values from the MES-induced seizure test) affected motor coordination in the chimney test, long-term memory in the passive avoidance task, and muscular strength in the grip-strength test in mice. This indicates no possible acute adverse effects in animals.

Conclusions:
IPPSMA-CA elevated the threshold for electroconvulsions in mice in a dose-dependent manner. However, IPPSMA-CA at a sub-protective dose of 100 mg/kg did not affect the anticonvulsant action of various classical AEDs in the mouse MES model. Thus, the combinations of IPPSMA-CA with CBZ, PB, PHT and VPA are neutral from a preclinical viewpoint.

 
REFERENCES (13)
1.
Rogawski MA, Bazil CW. New molecular targets for antiepileptic drugs: alpha (2)delta, SV2A, and K (v) 7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep. 2008; 8: 345-352.
 
2.
Kaminski K, Obniska J. Synthesis and anticonvulsant properties of new 1- (2-pyridinyl) – 3-substituted pyrrolidine-2,5-dione derivatives. Acta Pol Pharm. 2008; 65: 457-465.
 
3.
Lange J, Rump S, Gałecka E, Ilczuk I, Lechowska-Postek M, Rabsztyn T. Synthesis and properties of new cyclic derivatives of succinic acid with anticonvulsant activity. Pharmazie 1977; 32: 82-84.
 
4.
Łuszczki JJ, Kocharov SL, Czuczwar SJ. N- (anilinomethyl) -p-isopropoxyphenyl-succinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshockinduced seizure model. Neurosci Res. 2009; 64: 267-272.
 
5.
Zejc A, Obniska J, Wilimowski M, Rutkowska M, Witkowska M, Barczyńska J, Kędzierska-Goździk L, Wojewódzki W, Orzechowska- Juzwenko K, Pławiak T. Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides. Pol J Pharmacol Pharm. 1990; 42: 69-77.
 
6.
Łuszczki JJ, Kocharov SL, Czuczwar SJ. Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Pharmacol Rep. 2010; 62: 194-202.
 
7.
Łuszczki JJ, Cioczek JD, Kocharov SL, Andres-Mach M, Kominek M, Żółkowska D. Effects of three N- (carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Eur J Pharmacol. 2010; 648: 74-79.
 
8.
Łuszczki JJ, Kominek M, Florek-Łuszczki M, Tchaytchian DA, Kocharov SL, Żółkowska D. Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Epilepsy Res. 2012; 100: 27 36.
 
9.
Löscher W, Fassbender CP, Nolting B, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 1991; 8: 79-94.
 
10.
Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949; 96: 99-113.
 
11.
Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 1986; 321: 864–866.
 
12.
Meyer OA, Tilson HA, Byrd WC, Riley MT. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav Toxicol. 1979; 1: 233-236.
 
13.
Boissier JR, Tardy J, Diverres JC. Une nouvelle methode simple pour explorer l’action tranquilisante: le test de la cheminee. Med Exp. (Basel) 1960; 3: 81-84.
 
eISSN:1898-7516
ISSN:1898-2395
Journals System - logo
Scroll to top